Physician

Iryna Patel, M.D.

According to 2025 Medicare claims, Iryna Patel, M.D. (NPI: 1790168441) practices nephrology in the Carson City, NV market, with the plurality of this provider's patient population coming from Carson City, NV. This provider's primary affiliated billing organization is ONEILL CLARK NARVARTE & VICKS A PROFESSIONAL CORPORATION (NPI: 1962501940; TIN: 201405833) and primary practice location at 89701-9998.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 517 traditional Medicare patients, billed 1,486 HCPCS/CPT codes, and received $155,960 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 811 prescription claims across 199 beneficiaries totaling $397,731 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). 2023 DME data shows 56 claims. Open Payments data shows 31 records totaling $661. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $5,509 to $397,731. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	266	775	$83,588
2021	614	5,626	$376,358
2022	493	2,769	$228,584
2023	471	1,429	$160,490
2024	517	1,486	$155,960

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	30	89	$5,509
2019	94	665	$160,651
2020	88	417	$37,162
2021	123	473	$113,068
2022	120	567	$472,554
2023	112	378	$343,758
2024	199	811	$397,731

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	125	$2,500
2020	N/R	157	$4,191
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	56	$726
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	79	81	$132
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	124	334	$91
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	227	383	$71
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	75	150	$60
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	68	83	$58

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	80	2,460	$218,026
Farxiga	Dapagliflozin Propanediol	82	4,368	$77,181
Kerendia	Finerenone	17	690	$14,751
Lanthanum Carbonate	Lanthanum Carbonate	14	420	$7,736
Cinacalcet Hcl	Cinacalcet Hcl	29	1,616	$3,561

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	31	$661	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Iryna Patel, M.D.?

Tedicare shows public-source Medicare data for Iryna Patel, M.D. (NPI 1790168441), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Iryna Patel, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Iryna Patel, M.D.?

Iryna Patel, M.D. is linked to ONEILL CLARK NARVARTE & VICKS A PROFESSIONAL CORPORATION (billing NPI 1962501940) in the available physician profile data.

Does Iryna Patel, M.D. have Open Payments data?

Iryna Patel, M.D. has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.